AlphaYouPTHS: Pauls Matthew discloses a sale
By AlphaYouPublished Form 4
Pauls Matthew
Reporting filer
Pauls Matthew reported Sale in Pelthos Therapeutics Inc.: 786 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Pauls Matthew | 2026-10-02 | S | Sale | 786 | 21 | 13,578 | 4 days | Filed terms
|
Common Stock
- Owner
- Pauls Matthew
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 786
- Price
- 21
- Following holdings
- 13,578
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 786
- transaction Price Per Share: 21
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 13578
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Pauls Matthew: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
Original sources
Prepared automatically from public filing data. Report a correction.